Skip to main content
. 2021 Dec 18;18(24):13353. doi: 10.3390/ijerph182413353

Table 2.

Characteristics of studies included.

Population Characteristics Intervention Characteristics Outcome
Reference Country Sample Size Mean Age Status Type of Antihypertensive Drugs Dose Length Arterial Stiffness Parameter Measurement Device Baseline Levels
First author and year of publication Country in which the study data were collected Number of participants and percentage of female Age (years) of the participants range or mean ± SD Hypertension or Uncontrolled hypertension Antihypertensive drugs included in the list of drugs in Appendix A Dose administered and frequency Length (months) of treatment Type of arterial stiffness parameter (PWV, Aix, AASI, CAVI) Arterial stiffness parameter measuring device Baseline levels of the measured arterial stiffness parameter

Aix: augmentation index; AASI: ambulatory arterial stiffness index; CAVI: cardio-ankle vascular index; PWV: pulse wave velocity.